High on-treatment platelet reactivity in peripheral arterial disease: A systematic review

CONCLUSION: No consensus on technique or cut-off values for HTPR testing has been reached. Patients with HTPR are potentially at a greater risk of adverse limb-related and cardiovascular events than patients sensitive to antiplatelet therapy illustrating the need for clinical implementation of HTPR testing. Future research must aim for consistent methodology. Adaptation of antiplatelet therapy based on HTPR results requires further exploration.PMID:37950666 | DOI:10.1177/17085381231214324

Source: Vascular - November 11, 2023 Category: Surgery Authors: Lauren N Goncalves Veerle van Velze Frederikus A Klok Pim Gal Rimke C Vos Jaap F Hamming Koen E A van der Bogt Source Type: research